| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977907 | Brachytherapy | 2010 | 8 Pages |
Abstract
Preliminary biochemical control rates after EBRT plus one fraction of 9-Gy HDR-BT are encouraging. This atypical fractionation schedule is cost-effective and reduces patient discomfort and treatment-related risks. More followup is required to confirm these findings.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Francesca Pistis, Ferran Guedea, Joan Pera, Cristina Gutierrez, Montse Ventura, Alfredo Polo, Evelyn Martinez, Ana Boladeras, Ferran Ferrer, Pietro Gabriele, Luis Linares,